Evaluating the Efficacy of Personalized Medicine in Oncology
DOI:
https://doi.org/10.5281/k3x8cf07Resumen
Personalized medicine has transformed oncology by tailoring treatments to the genetic, molecular, and clinical characteristics of individual patients. This paper evaluates the efficacy of personalized medicine approaches in cancer care, focusing on targeted therapies, immunotherapy, and pharmacogenomics. By analyzing clinical trials and case studies, the research highlights the impact of personalized medicine on treatment outcomes, patient survival rates, and quality of life. Challenges such as accessibility, high costs, and ethical considerations are also discussed, with recommendations for enhancing the adoption of personalized approaches in oncology.
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2025 International Journal of Medical Sciences
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
All articles published in International Journal of Medical Sciences are licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows others to share, copy, distribute, and adapt the work for any purpose, even commercially, as long as appropriate credit is given to the original authors. Authors retain the copyright and agree to have their work published under this license, ensuring the broadest possible dissemination and reuse of their research.
For more information or licensing inquiries, contact mossdigital77@gmail.com.
